Factors mediating type 2 diabetes remission and relapse after gastric bypass surgery

Journal of the American College of Surgeons Nov 05, 2019

Pessoa BM, Browning MG, Mazzini GS, et al. - Via performing a retrospective review of 621 patients with type 2 diabetes (T2D) who underwent gastric bypass (RYGB) between 1993 and 2017, researchers sought to determine the factors linked with T2D remission and relapse after RYGB. Medication discontinuation and/or HbA1c < 6.5% T2D defined remission; recurrent medication use and/or HbA1c ≥ 6.5% defined relapse. Findings of this longitudinal retrospective analysis revealed that T2D remission and relapse following RYGB are influenced by preoperative insulin use and age, one-year weight loss, and regain. For improving the rates and durability of T2D remission, they emphasize referring patients at a younger age, before insulin is needed, and optimizing both weight loss and weight maintenance after RYGB.
Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay